Company History

Growing up in Shelbyville, Kentucky, E. Thomas Arington began sweeping the floors of Scofield’s Pharmacy in his early childhood years. This experience, along with the mentorship he received from Mr. & Mrs. James Scofield, grew his passion for and dedication to the pharmaceutical industry — eventually leading him to start Prasco in 2002. Since its inception, Prasco has been consistently recognized as one of the fastest growing companies in the generic industry.

When our first Authorized Generic launched in 2004, Prasco became a pioneer and leader in a new category that has since fueled the company’s growth, brought brand quality products to the generic segment, and saved patients billions of dollars. Prasco has developed strong partnerships with many of the largest and most trusted brand companies and has increased competition across the industry, resulting in more options at lower prices for consumers. And we’ve done all of this with passion and commitment to our “love God, love people” creed.

Timeline

2002
Prasco founded by E. Thomas Arington
Prasco founded by E. Thomas Arington
Launched first pharmaceutical product
Launched first pharmaceutical product
2004
Launched first Authorized Generic (AG)
Launched first Authorized Generic (AG)
2005
Launched first blockbuster Authorized Generic of Allegra (fexofenadine hcl) tablets.
Launched first blockbuster Authorized Generic of Allegra (fexofenadine hcl) tablets.
2008
Launched AG of top-selling generic product
Launched AG of top-selling generic product
Grand opening of Prasco’s new corporate headquarters in Mason, OH
Grand opening of Prasco’s new corporate headquarters in Mason, OH
2009
Launched 25th Authorized Generic
Launched 25th Authorized Generic
2012
Prasco Healthcare Services launch
Prasco Healthcare Services launch
2013
Launched 50th Authorized Generic
Launched 50th Authorized Generic
2014
Launched Blockbuster, Authorized Generic of Cymbalta (duloxetine) Capsules
Launched Blockbuster, Authorized Generic of Cymbalta (duloxetine) Capsules
2015
Prasco and affiliates purchase controlling shares of sister company, Aprecia
Prasco and affiliates purchase controlling shares of sister company, Aprecia
2016
Launched 75th Authorized Generic
Launched 75th Authorized Generic
Prasco expands portfolio through acquisition of first Cll product
Prasco expands portfolio through acquisition of first Cll product
2019
Launched 10th blockbuster Authorized Generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder)
Launched 10th blockbuster Authorized Generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder)
2020
Launched 100th Authorized Generic
Launched 100th Authorized Generic
Prasco expands AG portfolio through major acquisition from Pfizer/Mylan divestiture
Prasco expands AG portfolio through major acquisition from Pfizer/Mylan divestiture
2021
Prasco acquires Burel Pharma launching 1st Orphan Drug product
Prasco acquires Burel Pharma launching 1st Orphan Drug product
Prasco expands portfolio through 1st Hampton Laine launch of Estradiol Cream
Prasco expands portfolio through 1st Hampton Laine launch of Estradiol Cream
2022
Launched Authorized Generic of Blockbusters Flovent HFA (Fluticasone Propionate HFA Inhalation Aerosol) and Breo (Fluticasone Furoate/Vilanterol)
Launched Authorized Generic of Blockbusters Flovent HFA (Fluticasone Propionate HFA Inhalation Aerosol) and Breo (Fluticasone Furoate/Vilanterol)
2023
Prasco acquires Independence Pharmaceuticals expanding CII portfolio with ProCentra (dextroamphetamine sulfate)
Prasco acquires Independence Pharmaceuticals expanding CII portfolio with ProCentra (dextroamphetamine sulfate)
2024
Launched Authorized Generic of Blockbusters Farxiga (Dapagliflozin) and Xigduo (Dapagliflozin/Metformin ER)
Launched Authorized Generic of Blockbusters Farxiga (Dapagliflozin) and Xigduo (Dapagliflozin/Metformin ER)
Launched Authorized Generic of Sprycel (Dasatinib)
Launched Authorized Generic of Sprycel (Dasatinib)

Where to Go Next?

Find a Prasco Product

DB+